Globus Medical (GMED) Accumulated Depreciation & Amortization (2016 - 2025)
Globus Medical (GMED) has disclosed Accumulated Depreciation & Amortization for 14 consecutive years, with $276.8 million as the latest value for Q4 2025.
- For the quarter ending Q4 2025, Accumulated Depreciation & Amortization rose 9.26% year-over-year to $276.8 million, compared with a TTM value of $276.8 million through Dec 2025, up 9.26%, and an annual FY2025 reading of $276.8 million, up 9.26% over the prior year.
- Accumulated Depreciation & Amortization was $276.8 million for Q4 2025 at Globus Medical, down from $646.7 million in the prior quarter.
- Across five years, Accumulated Depreciation & Amortization topped out at $646.7 million in Q3 2025 and bottomed at $145.5 million in Q4 2023.
- Average Accumulated Depreciation & Amortization over 5 years is $348.8 million, with a median of $327.5 million recorded in 2022.
- The sharpest move saw Accumulated Depreciation & Amortization tumbled 57.58% in 2023, then skyrocketed 74.12% in 2024.
- Year by year, Accumulated Depreciation & Amortization stood at $305.6 million in 2021, then increased by 12.26% to $343.0 million in 2022, then crashed by 57.58% to $145.5 million in 2023, then surged by 74.12% to $253.4 million in 2024, then grew by 9.26% to $276.8 million in 2025.
- Business Quant data shows Accumulated Depreciation & Amortization for GMED at $276.8 million in Q4 2025, $646.7 million in Q3 2025, and $253.4 million in Q4 2024.